Show simple item record

dc.contributor.authorThongararm, Pennapa
dc.contributor.authorFedeles, Bogdan I.
dc.contributor.authorKhumsubdee, Sakunchai
dc.contributor.authorArmijo, Amanda L.
dc.contributor.authorCroy, Robert G.
dc.contributor.authorEssigmann, John M.
dc.date.accessioned2020-04-22T16:25:37Z
dc.date.available2020-04-22T16:25:37Z
dc.date.issued2019-12-16
dc.identifier.issn0893-228X
dc.identifier.issn1520-5010
dc.identifier.urihttps://hdl.handle.net/1721.1/124796
dc.description.abstractDNA methylating agents are abundant in the environment and are sometimes used in cancer chemotherapy. They react with DNA to form methyl-DNA adducts and byproduct lesions that can be both toxic and mutagenic. Foremost among the mutagenic lesions is O6-methylguanine (m6G), which base pairs with thymine during replication to cause GC → AT mutations. The gpt delta C57BL/6J mouse strain of Nohmi et al. (Mol. Mutagen 1996, 28, 465-70) reliably produces mutational spectra of many DNA damaging agents. In this work, mouse embryo fibroblasts (MEFs) were made from gpt delta C57BL/6J mice and evaluated as a screening tool to determine the qualitative and quantitative features of mutagenesis by N-methyl-N-nitrosourea (MNU), a direct-acting DNA alkylator that serves as a model for environmental N-nitrosamines, such as N-nitrosodimethylamine and therapeutic agents such as Temozolomide. The DNA repair protein MGMT (O6-methylguanine DNA methyltransferase) protects against environmental mutagenesis by DNA methylating agents and, by removing m6G, limits the therapeutic potential of Temozolomide in cancer therapy. The gpt delta MEFs were treated with MNU to establish dose-dependent toxicity. In parallel, MNU mutagenicity was determined in the presence and absence of the MGMT inhibitor AA-CW236 (4-(2-(5-(chloromethyl)-4-(4-(trifluoromethoxy)phenyl)-1H-1,2,3-triazol-1-yl)ethyl)-3,5-dimethylisoxazole). With and without the inhibitor, the principal mutagenic event of MNU was GC → AT, but more mutations were observed when the inhibitor was present. Evidence that the mutagenic lesion was m6G was based on mass spectral data collected using O6-methyl-d3-guanine as an internal standard; m6G levels were higher in AA-CW236 treated MEFs by an amount proportional to the higher mutation frequency seen in the same cells. This work establishes gpt delta MEFs as a versatile tool for probing mutagenesis by environmental and therapeutic agents and as a cell culture model in which chemical genetics can be used to determine the impact of DNA repair on biological responses to DNA damaging agents.en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Grant P30 ES002109)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Grant R01 CA080024)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Grant P42 ES027707)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Grant T32 ES007020)en_US
dc.language.isoen
dc.publisherAmerican Chemical Society (ACS)en_US
dc.relation.isversionof10.1021/acs.chemrestox.9b00444en_US
dc.rightsArticle is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.en_US
dc.sourcePMCen_US
dc.subjectToxicologyen_US
dc.subjectGeneral Medicineen_US
dc.titleModulation of N-Methyl-N-nitrosourea Mutagenesis in Mouse Embryo Fibroblasts Derived from the gpt Delta Mouse by an Inhibitor of the O6-Methylguanine Methyltransferase, MGMTen_US
dc.typeArticleen_US
dc.identifier.citationThongararm, Pennapa et al. “Modulation of N-Methyl-N-nitrosourea Mutagenesis in Mouse Embryo Fibroblasts Derived from the gpt Delta Mouse by an Inhibitor of the O6-Methylguanine Methyltransferase, MGMT.” Chemical research in toxicology 33 (2020): 625-633 © 2020 The Author(s)en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biological Engineeringen_US
dc.contributor.departmentMassachusetts Institute of Technology. Center for Environmental Health Sciencesen_US
dc.relation.journalChemical research in toxicologyen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2020-03-05T18:36:33Z
dspace.date.submission2020-03-05T18:36:35Z
mit.journal.volume33en_US
mit.journal.issue2en_US
mit.licensePUBLISHER_POLICY


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record